Pharmaceutical giant Pfizer has raised its full-year sales estimates for the COVID-19 vaccine to $45 billion. In the last quarter the company’s total sales reached almost $26 billion with $10 billion of that due to the vaccine.

Pharmaceutical giant Pfizer has raised its full-year sales estimates for the COVID-19 vaccine to $45 billion. In the last quarter the company’s total sales reached almost $26 billion with $10 billion of that due to the vaccine.
Tags Pfizer
The FTSE 100 fell on Friday in its worst day of trading since the start …
From black stars on European goods to apps showing what’s Canadian, consumers can respond to …